A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults
Greg Livermore, Bryony Hicks, Raffael Nachbagauer, Kathryn Jean Lucas et al.
Citations
38 citations
Journal
Vaccine
Topics
Influenza Virus Research Studies
Field-Weighted Citation Impact (FWCI)
51.46
article
A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults
Greg Livermore, Bryony Hicks, Raffael Nachbagauer, Kathryn Jean Lucas, Andrei Avanesov, Mieke Soens, Evelyn Du, Kristi Schaefers, Angela Choi, Jacqueline M. Miller, Carole Henry, José F. Cardona, Alicia Pucci, Rituparna Das, Lawrence Sher, Jintanat Ananworanich, Ren Chen
article en
38 citations
Abstract
No abstract available for this paper.
Publication Tag
VaccineVol. 50
Institutions
Lucas Research (US), Moderna Therapeutics (United States) (US), Peninsula Research (US), Micropharma (Canada) (CA), University of Science and Technology Chittagong (BD)